Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Rabstein

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Oncology Reports|January 17, 2009
Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancersSusanne Haas, Heidrun Gevensleben, Sylvia Rabstein, et al.
Breast Cancer Research and Treatment|October 28, 2009
No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer riskIrena E Andonova, Christina Justenhoven, Stefan Winter, et al.
Analytica Chimica Acta|August 26, 2018
Dilution correction for dynamically influenced urinary analyte dataJohannes Hertel, Markus Rotter, Stefan Frenzel, et al.
Scandinavian Journal of Work, Environment & Health|December 30, 2009
Night work and breast cancer - results from the German GENICA studyBeate Pesch, Volker Harth, Sylvia Rabstein, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancerBenny K Abraham, Christina Justenhoven, Beate Pesch, et al.
International Journal of Cancer|January 23, 2013
Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databasesJusto Lorenzo Bermejo, Maria Kabisch, Thomas Dünnebier, et al.
Scandinavian Journal of Work, Environment & Health|April 2, 2013
Night work and breast cancer estrogen receptor status--results from the German GENICA studySylvia Rabstein, Volker Harth, Beate Pesch, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 10, 2009
N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancerSylvia Rabstein, Thomas Brüning, Volker Harth, et al.
International Journal of Cancer|January 15, 2009
Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumorsChristina Justenhoven, Christiane B Pierl, Susanne Haas, et al.
Breast Cancer Research and Treatment|September 18, 2009
Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer riskThomas Dünnebier, Justo Lorenzo Bermejo, Susanne Haas, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Oncology Reports|January 17, 2009
Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancersSusanne Haas, Heidrun Gevensleben, Sylvia Rabstein, et al.
Breast Cancer Research and Treatment|October 28, 2009
No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer riskIrena E Andonova, Christina Justenhoven, Stefan Winter, et al.
Analytica Chimica Acta|August 26, 2018
Dilution correction for dynamically influenced urinary analyte dataJohannes Hertel, Markus Rotter, Stefan Frenzel, et al.
Scandinavian Journal of Work, Environment & Health|December 30, 2009
Night work and breast cancer - results from the German GENICA studyBeate Pesch, Volker Harth, Sylvia Rabstein, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancerBenny K Abraham, Christina Justenhoven, Beate Pesch, et al.
International Journal of Cancer|January 23, 2013
Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databasesJusto Lorenzo Bermejo, Maria Kabisch, Thomas Dünnebier, et al.
Scandinavian Journal of Work, Environment & Health|April 2, 2013
Night work and breast cancer estrogen receptor status--results from the German GENICA studySylvia Rabstein, Volker Harth, Beate Pesch, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 10, 2009
N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancerSylvia Rabstein, Thomas Brüning, Volker Harth, et al.
International Journal of Cancer|January 15, 2009
Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumorsChristina Justenhoven, Christiane B Pierl, Susanne Haas, et al.
Breast Cancer Research and Treatment|September 18, 2009
Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer riskThomas Dünnebier, Justo Lorenzo Bermejo, Susanne Haas, et al.
Pageof 6